D-Wave Quantum's Credibility Test Arrives as Record Bookings Collide with an 81% Revenue Plunge

D-Wave posted record $33.4M bookings but revenue crashed 81% to $2.86M, net loss widened. Stock fell 7.29% in Frankfurt; analysts positive with avg target $34.77. Technicals cautious, cash cushion $588M.

The central tension at D-Wave Quantum has rarely been starker: a surge in orders versus a collapse in sales. With $33.4 million in record bookings locked in during the latest quarter, the company has no shortage of customer interest. Yet the income statement tells a different story — revenue cratered 81% to $2.86 million from $15 million a year earlier, while the net loss widened to $18.36 million.

That disconnect is now the defining issue for the stock. Shares closed Friday at €17.48 in Frankfurt, shedding 7.29% for the session and leaving the year-to-date loss at 27.18%. Over a 12-month horizon, however, the equity still carries a 77.22% gain — a reminder of just how volatile this name has been. The market is demanding evidence that D-Wave can turn its order book into durable recurring revenue, not just occasional large-ticket sales.

A $20 million system sale to Florida Atlantic University and a $10 million enterprise deal together made up the bulk of those record bookings. But such lumpy transactions have yet to build the kind of predictable income stream analysts want to see. D-Wave is simultaneously selling expensive systems and building a subscription-based quantum computing service, a hybrid model that makes revenue jumps difficult to forecast.

Despite the fundamental headwinds, the sell-side remains broadly constructive. Several houses trimmed their price targets after the numbers but kept positive ratings. Mizuho lowered its target to $29 from $31 with an "Outperform" call. Canaccord went to $41 from $43, maintaining "Buy". Evercore ISI cut to $37 from $42 but stayed "Outperform". Jefferies held its target at $45 with a "Buy" rating. Across the 13 analysts covering the stock, the average price target still sits at $34.77.

The technical picture tilts cautious but not broken. At €17.48, the stock sits above the 50-day moving average of €15.68 but below the 200-day line at €20.01. The relative strength index of 34.9 points to already elevated selling pressure. On the US chart, the $20.00 area is watched as key support. A clean breakout above $22.22 would brighten the near-term outlook, while a failure beneath support could test the $17.20 zone. A potential inverse head-and-shoulders pattern remains in play, offering a bullish setup if it confirms.

Short interest, while still elevated, is easing. The short position stands at 52 million shares, down 11.5%, representing 14.5% of the free float. That decline suggests some bearish bets have been covered, but the level remains high enough to fuel any sharp upward move if sentiment shifts.

On the institutional side, Millennium Management disclosed a stake of roughly 2.27 million shares built by the end of 2024 — a sign that some big money sees long-term value in D-Wave's dual annealing-and-gate-model technology strategy. The company also carries a formidable cushion: $588.4 million in cash and marketable securities as of March 31, with negligible debt. That liquidity gives management time to execute, but it also raises the pressure to show that capital is being deployed effectively.

The coming weeks will test whether CEO Alan Baratz and his team can bridge the gap between hype and hard numbers. On May 20, D-Wave appears at J.P. Morgan's technology conference; the following day brings the Canaccord virtual quantum symposium. A TD Cowen TMT conference follows on May 28. Then on June 1, the company hosts its first-ever investor day at the New York Stock Exchange, followed by Qubits Europe in London on June 18.

At those events the focus will be narrow: how quickly the $33.4 million order backlog converts to recognized revenue, and whether the company can deliver on its promise of at least two system deployments this year, ramping to two or three annually thereafter. For a stock that lives on expectations as much as on results, the next few weeks could determine whether the record bookings become a launchpad or just another headline.